Home
Notes
Drug Dealin Podcast
Sponsorships
About BPS
Consulting
Home
Notes
Drug Dealin Podcast
Sponsorships
About BPS
Consulting
Subscribe
Sign in
Latest
Top
Discussions
Last Week Tonight in BioPharma: Week of June 29th, 2026
Anthropic wants to make drugs, a new "diva" in KRAS, Ipsen goes shopping, BridgeBio gets a "billy", and more!
Jul 5
•
Big Pharma Sharma
5
2
1
June 2026
Last Week Tonight in BioPharma: Week of June 22nd, 2026
Seagen ADC 2L NSCLC failure, Trump might be on retatrutide, US-China deal drama, and much more.
Jun 28
•
Big Pharma Sharma
7
1
Last Week Tonight in BioPharma, Week of June 15, 2026
Abbvie + Apogee, Neumora strikes out, Jazz bets on Abcellera, and the FDA starts to turn the page from the Prasad-Makary era.
Jun 22
•
Big Pharma Sharma
4
2
Cell Therapy is Making Progress Against Solid Tumors — But is Anyone Noticing?
Three under-the-radar cell therapy readouts from ASCO 2026 and where the near-term commercial future for this class may lie
Jun 18
•
Big Pharma Sharma
7
5
Last Week Tonight in BioPharma: Week of June 8th, 2026
A major GSK acquisition, Tango puts PRMT5 back on the radar, a record-setting IPO, and much more!
Jun 15
•
Big Pharma Sharma
10
1
ASCO 2026: Attention might be on the Wrong Drug in Frontline Lung Cancer
Sac-TMT may be unlike other TROP2 ADCs and poses a real threat to the PD-1xVEGF class in 1L NSCLC
Jun 9
•
Big Pharma Sharma
5
1
Last Week Tonight in BioPharma: Week of June 1st, 2026
RevMed PDAC data, IgAN opportunity, CAR-T for kidney transplant, NewLimit Series C, and much more
Jun 6
•
Big Pharma Sharma
7
4
May 2026
Last Week Tonight in BioPharma: Week of May 25th, 2026
Lilly' PCSK9 gene editing data, HBV functional cure, GLP-1 formulary update, Pfizer looks to China to reinvigorate its pipeline, and more!
May 31
•
Big Pharma Sharma
8
5
ChatGPT, Claude, or Gemini? Big Pharma Is Choosing Sides
I tracked 27 frontier-AI partnerships across 21 pharma companies. Here’s what the map looks like and what it means.
May 27
•
Big Pharma Sharma
10
3
Last Week Tonight in BioPharma: Week of May 18, 2026
Retatrutide wows, Sac-TMT continues to shine, Regeneron co-signs Parabilis, and much more!
May 24
•
Big Pharma Sharma
2
2
Last Week Tonight in BioPharma: Week of May 11th, 2026
Novo's early responders play, cleaning house at the FDA, IsoMorphic's $2.1B round, and more!
May 17
•
Big Pharma Sharma
3
2
1
We Know JAK About Myelofibrosis
Myelofibrosis treatment hasn't changed much for a long time. Is there a breakthrough on the horizon?
May 15
•
Big Pharma Sharma
3
2
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
